Skip to search.
 TSX Down 0.59% TSX Ventures Down 0.58%

OncoGenex Pharmaceuticals, Inc. (OGXI)

-NasdaqCM
0.54 Down 0.03(5.26%) Aug 31, 3:59PM EDT
Prev Close:0.57
Open:0.56
Bid:0.50 x 2000
Ask:1.00 x 5000
1y Target Est:1.95
Beta:1.86548
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:0.54 - 0.57
52wk Range:0.46 - 3.38
Volume:278,867
Avg Vol (3m):322,715
Market Cap:16.21M
P/E (ttm):N/A
EPS (ttm):-0.57
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
OGXIDown 5.26%16.21M
CELGDown 0.26%82.74B
PFEDown 0.23%211.08B
BMYUp 0.26%95.89B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):0.96
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.82
Quarterly EPS Est (Sep-16) :-0.26
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback